Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence

International Journal of Cancer

Volumn 82, Issue 2, 1999, Pages 175-179

  Huang, Chiun Sheng ^a   Chern, Herng Der ^b   Shen, Chen Yang ^c   Hsu, Su Ming ^a   Chang, King Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE;

ACETYLATOR PHENOTYPE; ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; POSTMENOPAUSE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SMOKING;

ACETYLATION; ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CARCINOGENS, ENVIRONMENTAL; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDROCARBONS, AROMATIC; INCIDENCE; LIFE STYLE; METABOLIC DETOXICATION, DRUG; PARITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POSTMENOPAUSE; REPRODUCTIVE HISTORY; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TAIWAN;

EID: 0033016237     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990719)82:2<175::AID-IJC4>3.0.CO;2-E     Document Type: Article

References (30)

1. AGUNDEZ, J.A., LADERO, J.M., OLIVERA, M., ABILDUA, R., ROMAN, J.M. and BENITEZ, J., Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients. Oncology, 52, 7-11 (1995).
2. AGUNDEZ, J.A., OLIVERA, M., LADERO, J.M., RODRIGUEZ-LESCURE, A., LEDESMA, M.C., DIAZ-RUBIO, M., MEYER, U.A. and BENITEZ, J., Increased risk for hepatocellular carcinoma in NATO-slow acetylators and CYP2D6-rapid metabolizers. Pharmacogenetics, 6, 501-512 (1996).
3. AMBROSONE, C.B., FREUDENHEIM, J.L., GRAHAM, S., MARSHALL, J.R., VENA, J.E., BRASURE, J.R., MICHALEK, A.M., LAUGHLIN R., NEMOTO, T., GILLENWATER, K.A., HARRINGTON, A.M. and SHIELDS, P.G., Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. J. Amer. med. Assoc., 276, 1494-1501 (1996).
4. BELL, D.A., TAYLOR, J.A., BUTLER, M.A., STEPHENS, E.A., WIEST, J., BRUBAKER, L.H., KADLUBAR, F.F. and LUCIER, G.W., Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT-2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis, 14, 1689-1692 (1993).
5. BLUM, M., DEMIERRE, A., GRANT, D.M., HEIM, M. and MEYER, U.A., Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. natl. Acad. Sci. (Wash.), 88, 5237-5241 (1991).
6. BLUM, M., GRANT, D.M., MCBRIDE, W., HEIM, M. and MEYER, U.A., Human arylamine N-acetyltransferase genes: isolation, chromosomal localization and functional expression. DNA Cell Biol., 9, 193-203 (1990).
7. CALAF, G. and RUSSO, J., Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis, 14, 483-492 (1993).
8. CHIE, W.C., LI, C.Y., HUANG, C.S., CHANG, K.J. and LIN, R.S., Body size as a factor in different ages and breast cancer risk in Taiwan. Anticancer Res., 18, 565-570 (1998).
9. DEGUCHI, T., MASHIMO, M. and SUZUKI, T., Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J. biol. Chem., 265, 12757-12760 (1990).
10. GRIMMER, G., NAUJACK, K.-W. and DETTBARN, G., Gaschromatographic determination of polycyclic aromatic hydrocarbons, aza-arenes, aromatic amines in the particle and vapor phase of mainstream and sidestream smoke of cigarettes. Toxicol. Lett., 35, 117-124 (1987).
11. HEIN, D.W., Acetylator genotype and arylamine-induced carcinogenesis. Biochim. biophys. Acta, 948, 37-66 (1988).
12. HUANG, C.S., SHEN, C.Y., CHANG, K.J., HSU, S.M. and CHERN, H.D., Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Brit. J. Cancer (1999). in press.
13. HUNTER, D.J., HANKINSON, S.E., HOUGH, H., GERTIG, D.M., GARCIA-CLOSAS, M., SPIEGELMAN, D., MANSON, J.E., COLDITZ, G.A., WILLETT, W.C., SPEIZER, F.E. and KELSEY K., A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis, 18, 2127-2132 (1997).
14. ILETT, K.F., DAVID, B.M., DETCHON, P., CASTLEDEN, W.M. and KWA, R., Acetylation phenotype in colorectal carcinoma. Cancer Res., 47, 1466-1469 (1987).
15. KADLUBAR, F.F., BUTLER, M.A., KADERLIK, K.R., CHOU, H.-C. and LANG, N.P., Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ. Health Perspect., 98, 69-74 (1992).
16. KU, W.H., LIU, I.L., YEN, M.S., CHANG CHIEN, C.C., YUE, C.T., MA, Y.Y., CHANG, S.F., NG, H.T., WU, C.W. and SHEN, C.Y., Genomic deletion and p53 inactivation in cervical carcinoma. Int. J. Cancer, 72, 270-276 (1997).
17. LI, D., WANG, M., DHINGRA, K. and HITTELMAN, W.N., Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res., 56, 287-293 (1996).
18. LIN, H.J., HAN, C.-Y., LIN, B.K. and HARDY, S., Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology. Amer. J. hum. Genet., 52, 827-834 (1993).
19. LO, Y.L., YU, J.C., HUANG, C.S., TSENG, S.L., CHANG, T.M., CHANG, K.J., WU, C.W. and SHEN, C.Y., Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset). Int. J. Cancer, 79, 580-587 (1998).
20. MADIGAN, M.P., ZIEGLER, R.G., BENICHOU, J., BYRNE, C. and HOOVER, R.N., Proportion of breast cancer cases in the United States explained by well-established risk factors. J. nat. Cancer Inst., 87, 1681-1685 (1995).
21. MASHIMO, M., SUZUKI, T., ABE, M. and DEGUCHI, T., Molecular genotyping of N-acetylation polymorphism to predict phenotype. Hum. Genet., 90, 139-143 (1992).
22. MILLIKAN, R.C., PITTMAN, G.S., NEWMAN, B., TSE, CK.J., SELMIN, O., ROCKHILL, B., SAVITZ, D., MOORMAN, P.G. and BELL, D.A., Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol. Biomarker Prev., 7, 371-378 (1998).
23. PROBST, M.R., BLUM, M., FASSHAUER, I., D'ORAZIO, D., MEYER, U.A. and WILD, D., The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo [4,5-f] quinoline (IQ). Carcinogenesis, 13, 1713-1717 (1992).
24. RUSSO, J. and RUSSO, I.H., Biological and molecular bases of mammary carcinogenesis. Lab. Invest., 57, 112-137 (1987).
25. TSENG, S.L., YU, J.C., YUE, C.T., CHANG, S.F., CHANG, T.M., WU, C.W. and SHEN, C.Y., Allelic loss at BRCA1, BKCA2 and adjacent loci in relation to TP53 abnormality in breast cancer. Genes Chromosomes Cancer, 20, 377-382 (1997).
26. VINEIS, P., BARTSCH, H., CAPORASO, N., HARRINGTON, A.M., KADLUBAR, F.F., LANDI, M.T., MALAVEILLE, C., SHIELDS, P.G., SKIPPER, P., TALASKA, G. and TANNENBAUM, S.R., Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature (Lond.) 369, 154-156 (1994).
27. WELFARE, M.R., COOPER, J., BASSENDINE, M.F. and DALY, A.K., Relationship between acetylator status, smoking, diet and colorectal cancer risk in the north-east of England. Carcinogenesis, 18, 1351-1354 (1997).
28. WOHLLEB, J.C., HUNTER, C.F., BLASS, B., KADLUBAR, F.F., CHU, D.Z. and LANG, N.P., Aromatic amine acetyltransferase as a marker for colorectal cancer: environmental and demographic associations. Int. J. Cancer, 46, 22-30 (1990).
29. XIE, H.G., XU, Z.H., OU-YANG, D.S., SHU, Y., YANG, D.L., WANG, J.S., YAN, X.D., HUANG, S.L., WANG, W. and ZHOU, H.H., Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations. Pharmacogenetics, 7, 503-514 (1997).
30. YANG, P.S., YANG, T.L., LIU, C.L., WU, C.W. and SHEN, C.Y., A case-control study of breast cancer in Taiwan - a low-incidence area. Brit. J. Cancer, 75, 752-756 (1997).